Dare Bioscience Inc (NAS:DARE)
$ 3.18 -0.01 (-0.31%) Market Cap: 27.75 Mil Enterprise Value: 21.41 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 35/100

Q2 2024 Dare Bioscience Inc Earnings Call Transcript

Aug 12, 2024 / 08:30PM GMT
Release Date Price: $3.5 (+3.24%)
Operator

Welcome to the conference call hosted by Daré Bioscience to review the company's second quarter financial results and to provide a general business update. This call is being recorded. My name is Leonardo, and I will be your operator today.

With us today from Daré are Sabrina Martucci Johnson, President and Chief Executive Officer; and MarDee Haring-Layton, Chief Accounting Officer.

Ms. Haring-Layton, please proceed.

MarDee Haring;Layton
Dare Bioscience Inc. - Chief Accounting Officer

Good afternoon, and welcome to the Daré Bioscience financial results and business update call for the quarter ended June 30, 2024. Today, we will review our second quarter results and discuss developments and expectations for our pipeline and portfolio.

I'd like to remind you that today's discussion will include forward-looking statements within the meaning of federal securities laws, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Any statements made during this call

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot